Ivermectin Repurposed for the Treatment of PKDL
NCT07286604
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Post Kala Azar Dermal Leishmaniasis
Interventions
DRUG:
Ivermectin 6 MG Oral Tablet (2 tablets)
Sponsor
International Centre for Diarrhoeal Disease Research, Bangladesh